Dean Mitchell

Mr. Dean J.
Mitchell is an Independent Chairman at Praxis Precision Medicines, Inc. and a Lead Independent Director at Theravance Biopharma, Inc. He is on the Board of Directors at Theravance Biopharma, Inc. Mr. Mitchell was previously employed as a Chairman by Kinnate Biopharma, Inc., a Chairman by PaxVax, Inc., a Chairman by Paxvax Corp., a Chairman by Covis Pharma Holdings BV, an Executive Chairman by Covis Pharma Holdings SARL, an Independent Director by ImmunoGen, Inc., a President, Chief Executive Officer & Director by Lux Biosciences, Inc., an Independent Director by Precigen, Inc., a President, Chief Executive Officer & Director by Alpharma LLC, a President & Chief Executive Officer by Alpharma LLC, a President by MGI GP, Inc., a Non-Executive Director by MGI PHARMA, Inc., a President, Chief Executive Officer & Director by Guilford Pharmaceuticals, Inc., a President-International Pharmaceuticals by Bristol Myers Squibb Co., a Senior VP-Clinical Development & Product Strategy by GlaxoSmithKline Plc, and a Chairman by National Pharmaceutical Council.
He also served on the board at Talecris Biotherapeutics Holdings Corp.
and ISTA Pharmaceuticals, Inc. He received his undergraduate degree from Coventry University and an MBA from Bayes Business School.